Marriott's 17% Rally Draws Analyst Upgrades Before November Print

MAR has gained 17% over the past month to $397.31, and the Street responded this week with a coordinated round of target-price increases that now point just as much to where the stock has already been as to where it is going.

JP Morgan's Daniel Politzer raised his target to $406 on Tuesday while keeping a Neutral rating. That is a meaningful signal: even with the stock within reach of his new number, he did not upgrade. Evercore ISI lifted to $420 and Wells Fargo to $426, both maintaining positive ratings. Morgan Stanley raised to $384 on October 12. The direction of travel is unanimously higher, but the consensus price target of $387 sits below the current price, meaning the median analyst is not chasing the rally. Barclays moved to $363, reflecting a more cautious assessment of where fair value lies.

Short interest is low and tells no dramatic story here. Bears hold about 2.6% of the free float, a position that has edged up roughly 4% over the week in share terms but remains well within normal range. Borrowing costs are negligible at 0.47%. Availability in the lending market is extremely wide, with over 3,000% availability relative to shares already lent, meaning the pool of shares available to borrow vastly outstrips any short demand. There is no squeeze dynamic and no meaningful bearish conviction in the positioning data.

Options are similarly unremarkable. The put/call ratio is 0.89, fractionally below its 20-day average of 0.91 and well within a single standard deviation of that mean. The PCR has been drifting lower from the 1.02 reading hit on October 8, meaning options traders have been gradually reducing their hedging as the stock climbed. That is consistent with the price action rather than in tension with it.

The family-controlled ownership structure adds a layer of nuance. J.W. Marriott, Jr. filed a Schedule 13D/A in January disclosing an 11.4% stake, a filing type that typically signals active ownership intent rather than passive holding. Three family members, including board director David S. Marriott and director Deborah Marriott Harrison, each sold 3,500 shares at roughly $352 in late September. These were open-market disposals, not compensation mechanics, totalling around $1.2 million each. The sales came roughly 13% below the current price, which means the sellers have left money on the table in the rally since. Stakes in the 13D register are as-last-disclosed and positions can change without a further filing until they cross back through the 5% threshold. BlackRock holds 6.2% and added 558,000 shares in the September quarter; JP Morgan Asset Management added 850,000 shares in the same period, a meaningful build for an institution that size.

The company reports Q3 results on November 2, twelve days away. Recent prints have punished the stock: it fell 7.4% on the day after the last earnings release and a further 6.5% over the following five days, and the August 2026 print similarly produced a 2% one-day loss. The bull case rests on RevPAR growth of 2 to 3% for 2026 and gross fees guided to $5.93 to $5.99 billion, with Q1 EBITDA already at $1.4 billion. The bear case centres on North America concentration at 61% of rooms, China deterioration, and slowing construction financing that could cap the development pipeline. With the stock now above most analyst targets and two consecutive post-earnings declines in the record, the November 2 release is the event that matters most in the near term.